Cargando…
ABO blood grouping and COVID-19: a hospital-based study in Eastern India
BACKGROUND: Blood group has been stated to be one of the risk factors associated with viral diseases like dengue, hepatitis virus, Norwalk virus and even the coronavirus associated with 2003 severe acute respiratory syndrome (SARS) outbreak. In addition, anti-A antibodies in experimental models have...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769779/ https://www.ncbi.nlm.nih.gov/pubmed/37521837 http://dx.doi.org/10.1186/s43042-022-00225-9 |
_version_ | 1784635217752883200 |
---|---|
author | Behera, Birasen Rout, Bidyutprava RajashreePanigrahy Kar, Subrat Kumar Sahoo, Debasish Sahu, Kundan Kumar Otta, Sarita |
author_facet | Behera, Birasen Rout, Bidyutprava RajashreePanigrahy Kar, Subrat Kumar Sahoo, Debasish Sahu, Kundan Kumar Otta, Sarita |
author_sort | Behera, Birasen |
collection | PubMed |
description | BACKGROUND: Blood group has been stated to be one of the risk factors associated with viral diseases like dengue, hepatitis virus, Norwalk virus and even the coronavirus associated with 2003 severe acute respiratory syndrome (SARS) outbreak. In addition, anti-A antibodies in experimental models have been shown to inhibit the interaction between coronavirus and angiotensin converting enzyme (ACE) receptor of the host target cell, the major receptor involved in viral pathogenesis. Thus, several workers propose an association between ABO blood type and coronavirus disease- 2019 (COVID-19) disease in many previous studies. The present study was undertaken in the Eastern part of India in line with these authors to study the association of ABO blood group of patients with COVID susceptibility and severity. METHODS: This is a retrospective study over a period of 6 months from June 2020 to November 2020 where patients who underwent quantitative real-time polymerase chain reaction (qRT-PCR) test for SARS-COV2 and having a recorded patient blood group type were considered. The qRT-PCR positive admitted cases were considered as cases, and qRT-PCR negative cases were considered as controls. Data were entered in Microsoft Excel format and analyzed by statistical method to obtain association. RESULTS: Consecutively obtained 5000 qRT-PCR positive patients (cases) and 11,700 (controls) were included in the present study. The mean age of cases was higher (54.24 vs. 34. 67) than the controls. Among the cases, the highest number (2379; 47.6%) of samples belonged to A blood group followed by B (1278; 25.6%) while among the control group O blood group had the highest prevalence (4215; 36%). Blood group A had a higher odd of testing positive (Odds ratio-2.552; CI 2.381–2.734; p < 0.0001) than all other blood groups. A blood group is also associated with higher risk of ICU admission (Odds ratio- 1.699; 95% CI 1.515–1.905) and 65.3% of this group is also associated with high viral load which gives an indication of higher disease severity. CONCLUSION: Blood group A is associated with an increased susceptibility to COVID 19 infection than other blood groups. Cases of this blood group are also associated with more critical care needs and a higher viral load on testing. |
format | Online Article Text |
id | pubmed-8769779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-87697792022-01-20 ABO blood grouping and COVID-19: a hospital-based study in Eastern India Behera, Birasen Rout, Bidyutprava RajashreePanigrahy Kar, Subrat Kumar Sahoo, Debasish Sahu, Kundan Kumar Otta, Sarita Egypt J Med Hum Genet Research BACKGROUND: Blood group has been stated to be one of the risk factors associated with viral diseases like dengue, hepatitis virus, Norwalk virus and even the coronavirus associated with 2003 severe acute respiratory syndrome (SARS) outbreak. In addition, anti-A antibodies in experimental models have been shown to inhibit the interaction between coronavirus and angiotensin converting enzyme (ACE) receptor of the host target cell, the major receptor involved in viral pathogenesis. Thus, several workers propose an association between ABO blood type and coronavirus disease- 2019 (COVID-19) disease in many previous studies. The present study was undertaken in the Eastern part of India in line with these authors to study the association of ABO blood group of patients with COVID susceptibility and severity. METHODS: This is a retrospective study over a period of 6 months from June 2020 to November 2020 where patients who underwent quantitative real-time polymerase chain reaction (qRT-PCR) test for SARS-COV2 and having a recorded patient blood group type were considered. The qRT-PCR positive admitted cases were considered as cases, and qRT-PCR negative cases were considered as controls. Data were entered in Microsoft Excel format and analyzed by statistical method to obtain association. RESULTS: Consecutively obtained 5000 qRT-PCR positive patients (cases) and 11,700 (controls) were included in the present study. The mean age of cases was higher (54.24 vs. 34. 67) than the controls. Among the cases, the highest number (2379; 47.6%) of samples belonged to A blood group followed by B (1278; 25.6%) while among the control group O blood group had the highest prevalence (4215; 36%). Blood group A had a higher odd of testing positive (Odds ratio-2.552; CI 2.381–2.734; p < 0.0001) than all other blood groups. A blood group is also associated with higher risk of ICU admission (Odds ratio- 1.699; 95% CI 1.515–1.905) and 65.3% of this group is also associated with high viral load which gives an indication of higher disease severity. CONCLUSION: Blood group A is associated with an increased susceptibility to COVID 19 infection than other blood groups. Cases of this blood group are also associated with more critical care needs and a higher viral load on testing. Springer Berlin Heidelberg 2022-01-20 2022 /pmc/articles/PMC8769779/ /pubmed/37521837 http://dx.doi.org/10.1186/s43042-022-00225-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Behera, Birasen Rout, Bidyutprava RajashreePanigrahy Kar, Subrat Kumar Sahoo, Debasish Sahu, Kundan Kumar Otta, Sarita ABO blood grouping and COVID-19: a hospital-based study in Eastern India |
title | ABO blood grouping and COVID-19: a hospital-based study in Eastern India |
title_full | ABO blood grouping and COVID-19: a hospital-based study in Eastern India |
title_fullStr | ABO blood grouping and COVID-19: a hospital-based study in Eastern India |
title_full_unstemmed | ABO blood grouping and COVID-19: a hospital-based study in Eastern India |
title_short | ABO blood grouping and COVID-19: a hospital-based study in Eastern India |
title_sort | abo blood grouping and covid-19: a hospital-based study in eastern india |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769779/ https://www.ncbi.nlm.nih.gov/pubmed/37521837 http://dx.doi.org/10.1186/s43042-022-00225-9 |
work_keys_str_mv | AT beherabirasen abobloodgroupingandcovid19ahospitalbasedstudyineasternindia AT routbidyutprava abobloodgroupingandcovid19ahospitalbasedstudyineasternindia AT rajashreepanigrahy abobloodgroupingandcovid19ahospitalbasedstudyineasternindia AT karsubratkumar abobloodgroupingandcovid19ahospitalbasedstudyineasternindia AT sahoodebasish abobloodgroupingandcovid19ahospitalbasedstudyineasternindia AT sahukundankumar abobloodgroupingandcovid19ahospitalbasedstudyineasternindia AT ottasarita abobloodgroupingandcovid19ahospitalbasedstudyineasternindia |